Clinical Trial Update: A Study Evaluating the Bioequivalence of VIAject®7 Compared to VIAject®25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject®7 to Insulin Lispro in Subjects With Type 1 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial reports on the bioequivalence of VIAject 7 to VIAject 25 and compares the pharmacokinetic and pharmacodynamic properties of VIAject 7 wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• VIAject 25
• Viaject 7
• insulin lispro (insulin lispro)

Snippet

Sponsor: Biodel | Conditions: Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED